These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 36587812

  • 1. Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC.
    He Q, Ma Y, Fang C, Deng Z, Wang F, Qu Y, Yin M, Zhao R, Zhang D, Guo F, Yang Y, Chang J, Guo ZN.
    Pharmacol Res; 2023 Jan; 187():106641. PubMed ID: 36587812
    [Abstract] [Full Text] [Related]

  • 2. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ, Cao C, Fredriksson L, Nilsson I, Stefanitsch C, Stevenson TK, Zhao J, Ragsdale M, Sun YY, Yepes M, Kuan CY, Eriksson U, Strickland DK, Lawrence DA, Zhang L.
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [Abstract] [Full Text] [Related]

  • 3. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y, Li L, Kong L, Zhu Z, Zhang W, Song J, Chang J, Du G.
    Biomed Res Int; 2018 Oct; 2018():8943210. PubMed ID: 29850586
    [Abstract] [Full Text] [Related]

  • 4. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
    Jean LeBlanc N, Menet R, Picard K, Parent G, Tremblay MÈ, ElAli A.
    Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
    [Abstract] [Full Text] [Related]

  • 5. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.
    Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M, Strickland DK, Betsholtz C, Eriksson U, Lawrence DA.
    Nat Med; 2008 Jul; 14(7):731-7. PubMed ID: 18568034
    [Abstract] [Full Text] [Related]

  • 6. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models.
    Qiu L, Cai Y, Geng Y, Yao X, Wang L, Cao H, Zhang X, Wu Q, Kong D, Ding D, Shi Y, Wang Y, Wu J.
    Acta Biomater; 2022 Dec; 154():424-442. PubMed ID: 36367475
    [Abstract] [Full Text] [Related]

  • 7. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.
    Guo Z, Yu S, Chen X, Zheng P, Hu T, Duan Z, Liu X, Liu Q, Ye R, Zhu W, Liu X.
    Brain Res Bull; 2018 Mar; 137():229-240. PubMed ID: 29258866
    [Abstract] [Full Text] [Related]

  • 8. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W, Li M, Wang Y, Li Q, Deng G, Wan J, Yang Q, Chen Q, Wang J.
    Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
    [Abstract] [Full Text] [Related]

  • 9. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY, Chung JI, Jalin AMA, Ju C, Pahk K, Joung C, Lee S, Jin S, Kim BS, Lee KS, Ryu JM, Kim WK.
    Int J Mol Sci; 2022 Jan 26; 23(3):. PubMed ID: 35163322
    [Abstract] [Full Text] [Related]

  • 10. GAS6/Axl Signaling Modulates Blood-Brain Barrier Function Following Intravenous Thrombolysis in Acute Ischemic Stroke.
    Guo ZN, Liu J, Chang J, Zhang P, Jin H, Sun X, Yang Y.
    Front Immunol; 2021 Jan 26; 12():742359. PubMed ID: 34733281
    [Abstract] [Full Text] [Related]

  • 11. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
    Niego B, Medcalf RL.
    J Cereb Blood Flow Metab; 2014 Aug 26; 34(8):1283-96. PubMed ID: 24896566
    [Abstract] [Full Text] [Related]

  • 12. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
    Yang X, Chu H, Tang Y, Dong Q.
    Neuroscience; 2016 Aug 04; 329():54-65. PubMed ID: 27138645
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y, Shimura H, Tanaka R, Yamashiro K, Koike M, Uchiyama Y, Urabe T, Hattori N.
    PLoS One; 2018 Aug 04; 13(5):e0198039. PubMed ID: 29795667
    [Abstract] [Full Text] [Related]

  • 14. Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator.
    Rodríguez-González R, Blanco M, Rodríguez-Yáñez M, Moldes O, Castillo J, Sobrino T.
    Atherosclerosis; 2013 Jan 04; 226(1):165-71. PubMed ID: 23218119
    [Abstract] [Full Text] [Related]

  • 15. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L, Fan W, Cai P, Fan M, Zhu X, Dai Y, Sun C, Cheng Y, Zheng P, Zhao BQ.
    Ann Neurol; 2013 Feb 04; 73(2):189-98. PubMed ID: 23280993
    [Abstract] [Full Text] [Related]

  • 16. GLP-1R Agonist Exendin-4 Protects Against Hemorrhagic Transformation Induced by rtPA After Ischemic Stroke via the Wnt/β-Catenin Signaling Pathway.
    Liu C, Sun S, Xie J, Li H, Li T, Wu Q, Zhang Y, Bai X, Wang J, Wang X, Li Z, Wang W.
    Mol Neurobiol; 2022 Jun 04; 59(6):3649-3664. PubMed ID: 35359227
    [Abstract] [Full Text] [Related]

  • 17. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):148-54. PubMed ID: 25292413
    [Abstract] [Full Text] [Related]

  • 18. Vascular PDGFR-alpha protects against BBB dysfunction after stroke in mice.
    Nguyen QL, Okuno N, Hamashima T, Dang ST, Fujikawa M, Ishii Y, Enomoto A, Maki T, Nguyen HN, Nguyen VT, Fujimori T, Mori H, Andrae J, Betsholtz C, Takao K, Yamamoto S, Sasahara M.
    Angiogenesis; 2021 Feb 15; 24(1):35-46. PubMed ID: 32918673
    [Abstract] [Full Text] [Related]

  • 19. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Oka S, Namioka T, Namioka A, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Mikami T, Wanibuchi M, Kocsis JD, Honmou O.
    J Neurosurg; 2017 Oct 15; 127(4):917-926. PubMed ID: 28059661
    [Abstract] [Full Text] [Related]

  • 20. Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke.
    Huang Y, Gu S, Han Z, Yang Z, Zhong L, Li L, Wang R, Yan F, Luo Y, Borlongan C, Lu J.
    J Am Heart Assoc; 2023 Sep 05; 12(17):e029817. PubMed ID: 37655472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.